Companies / ProteinQure
| Round | Date | Amount | Investors |
|---|---|---|---|
| Grant | May 25, 2026 | C$1.8M | FedDev Ontario (lead) |
| Series A | May 28, 2025 | C$11M | Heron Rock Fund (lead); Golden Ventures, Kensington Capital Partners. All-primary, all-equity; led by Heron Rock Fund (Tom Williams); Golden Ventures and Kensington Capital Partners participated; funds first clinical trial (triple-negative breast cancer); currency per BetaKit and The Logic (no US$ marker) |
Data as of September 26, 2026. Suggest a correction